VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 106 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,636 | +62.9% | 20,082 | +140.7% | 0.00% | – |
| Q2 2023 | $95,539 | +18132.6% | 8,344 | +12170.6% | 0.00% | – |
| Q1 2023 | $524 | +26.3% | 68 | 0.0% | 0.00% | – |
| Q4 2022 | $415 | -99.9% | 68 | 0.0% | 0.00% | – |
| Q3 2022 | $403,000 | -55.7% | 68 | -55.8% | 0.00% | – |
| Q2 2022 | $910,000 | -29.3% | 154 | -8.9% | 0.00% | – |
| Q1 2022 | $1,288,000 | +181.2% | 169 | 0.0% | 0.00% | – |
| Q4 2021 | $458,000 | +3.2% | 169 | 0.0% | 0.00% | – |
| Q3 2021 | $444,000 | +28.0% | 169 | +101.2% | 0.00% | – |
| Q2 2021 | $347,000 | -98.4% | 84 | -98.2% | 0.00% | – |
| Q1 2021 | $22,076,000 | -53.6% | 4,687 | -29.5% | 0.00% | – |
| Q4 2020 | $47,533,000 | -27.7% | 6,648 | +8.0% | 0.00% | – |
| Q3 2020 | $65,706,000 | +58.6% | 6,158 | +87.6% | 0.00% | – |
| Q2 2020 | $41,431,000 | -70.7% | 3,283 | -78.7% | 0.00% | – |
| Q1 2020 | $141,203,000 | +263.6% | 15,432 | +454.3% | 0.00% | – |
| Q4 2019 | $38,837,000 | -36.2% | 2,784 | -21.3% | 0.00% | – |
| Q3 2019 | $60,906,000 | -6.6% | 3,539 | +47.7% | 0.00% | – |
| Q2 2019 | $65,219,000 | -24.1% | 2,396 | -46.7% | 0.00% | – |
| Q1 2019 | $85,977,000 | +153430.4% | 4,492 | +74766.7% | 0.00% | – |
| Q4 2018 | $56,000 | -99.6% | 6 | -99.2% | 0.00% | – |
| Q3 2018 | $13,452,000 | -3.2% | 711 | 0.0% | 0.00% | – |
| Q2 2018 | $13,893,000 | -78.5% | 711 | -79.3% | 0.00% | – |
| Q1 2018 | $64,675,000 | -2.1% | 3,442 | -13.5% | 0.00% | – |
| Q4 2017 | $66,068,000 | +207.7% | 3,980 | +281.6% | 0.00% | – |
| Q3 2017 | $21,475,000 | +117.5% | 1,043 | -5.4% | 0.00% | – |
| Q2 2017 | $9,874,000 | +37876.9% | 1,102 | +55000.0% | 0.00% | – |
| Q1 2017 | $26,000 | -98.2% | 2 | -98.2% | 0.00% | – |
| Q4 2016 | $1,414,000 | -85.2% | 111 | -86.0% | 0.00% | – |
| Q3 2016 | $9,548,000 | +53.5% | 795 | +40.5% | 0.00% | – |
| Q2 2016 | $6,220,000 | +657.6% | 566 | +502.1% | 0.00% | – |
| Q1 2016 | $821,000 | -96.4% | 94 | -91.0% | 0.00% | – |
| Q4 2015 | $22,996,000 | – | 1,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |